These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30444700)

  • 1. Attention-deficit/hyperactivity disorder: clinical pharmacology and dental implications.
    Mousavian MM; Saraghi M; Hersh EV
    Gen Dent; 2018; 66(6):9-11. PubMed ID: 30444700
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-Induced Oral Complications.
    Ikeda K
    Atlas Oral Maxillofac Surg Clin North Am; 2017 Sep; 25(2):127-132. PubMed ID: 28778302
    [No Abstract]   [Full Text] [Related]  

  • 3. Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).
    Kollins SH
    Am J Addict; 2007; 16 Suppl 1():35-42; quiz 43-4. PubMed ID: 17453605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-deficit/hyperactivity disorder and substance abuse.
    Harstad E; Levy S;
    Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome.
    Konofal E; Arnulf I; Lecendreux M; Mouren MC
    Pediatr Neurol; 2005 May; 32(5):350-1. PubMed ID: 15866437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children.
    Mosholder AD; Gelperin K; Hammad TA; Phelan K; Johann-Liang R
    Pediatrics; 2009 Feb; 123(2):611-6. PubMed ID: 19171629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention-deficit/hyperactivity disorder and sleep disorders in children.
    Tsai MH; Huang YS
    Med Clin North Am; 2010 May; 94(3):615-32. PubMed ID: 20451036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathophysiology, medical management, and dental implications of children and young adults having attention-deficit hyperactivity disorder.
    Friedlander AH; Yagiela JA; Paterno VI; Mahler ME
    J Calif Dent Assoc; 2003 Sep; 31(9):669-78. PubMed ID: 14560871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacotherapy of Attention Deficit-Hyperactivity Disorder in Children with Comorbid Conditions.
    Naguy A
    Pediatr Neurol; 2018 May; 82():7-12. PubMed ID: 29678368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapeutic challenges in treatment of a child with "the triad" of obsessive compulsive disorder, attention-deficit/hyperactivity disorder and Tourette's disorder.
    Rice T; Coffey B
    J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):176-9. PubMed ID: 25782100
    [No Abstract]   [Full Text] [Related]  

  • 11. Does Restless Legs Syndrome increase cardiovascular risk in Attention-Deficit/Hyperactivity Disorder?
    Angriman M; Bruni O; Cortese S
    Med Hypotheses; 2013 Jan; 80(1):39-42. PubMed ID: 23111202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of childhood onset pervasive developmental disorder and attention deficit disorder with hyperactivity.
    Geller B; Guttmacher LB; Bleeg M
    Am J Psychiatry; 1981 Mar; 138(3):388-9. PubMed ID: 7468843
    [No Abstract]   [Full Text] [Related]  

  • 13. Attention deficit hyperactivity disorder and substance misuse: an evaluation of causal hypotheses and treatment considerations.
    Young S; Sedgwick O
    Expert Rev Neurother; 2015; 15(9):1005-14. PubMed ID: 26289485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible antienuretic effect of reboxetine in children and adolescents with attention deficit/hyperactivity disorder: case series.
    Toren P; Ratner S; Laor N; Lerer-Amisar D; Weizman A
    Neuropsychobiology; 2005; 51(4):239-42. PubMed ID: 15897675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The evaluation of the effects of pharmacological treatment of children with attention deficit hyperactivity disorder].
    Roselló B; Amado L; Presentación MJ
    Rev Neurol; 1999 Feb; 28 Suppl 2():S177-82. PubMed ID: 10778510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention deficit/hyperactivity disorder medication and dental caries in children.
    Rosenberg SS; Kumar S; Williams NJ
    J Dent Hyg; 2014 Dec; 88(6):342-7. PubMed ID: 25534686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: preliminary clinical experience.
    Riddle MA; Hardin MT; Cho SC; Woolston JL; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 1988 Nov; 27(6):811-4. PubMed ID: 3198572
    [No Abstract]   [Full Text] [Related]  

  • 18. The Effect of Atomoxetin Use in the Treatment of Attention-Deficit/Hyperactivity Disorder on the Symptoms of Restless Legs Syndrome: A Case Report.
    Baykal S; Karakurt MN
    Clin Neuropharmacol; 2017; 40(2):93-94. PubMed ID: 28195837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.
    Jain R; Segal S; Kollins SH; Khayrallah M
    J Am Acad Child Adolesc Psychiatry; 2011 Feb; 50(2):171-9. PubMed ID: 21241954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.